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Plastic and reconstructive surgery is charac-terized by its emphases on problem-solving, rich diversity of procedures, and collabora-
tive role with several surgical specialties. Proficient 
in not only a singular anatomical system, the spe-
cialty fosters creativity, entrepreneurship, and a 
degree of surgeon autonomy.1–4 Indeed, inno-
vation has played a defining role in plastic and 
reconstructive surgery since its origins. Harold 
Gillies used staged reconstruction to restore the 
faces of veterans during World War I.5,6 Joseph 
Murray won a Nobel Prize for completing the 
first successful human kidney transplant.6,7 The 
first microvascular anastomosis using an operat-
ing microscope was performed in 1960,8 soon fol-
lowed by the first arm replantation in 1964.9 Of 
the 50 most cited plastic and reconstructive sur-
gery articles, nearly half introduced or modified a 
surgical technique.10 It follows that continual and 
widespread adoption of innovations is necessary 
for the advancement and survival of the specialty.
Although research is considered a prereq-
uisite for driving innovation,11 the process from 
ideation to implementation typically takes many 
decades.12 Our goals herein are three-fold: (1) 
to call attention to contemporary challenges for 
safe and ethical innovation in plastic and recon-
structive surgery, (2) to discuss how the emerg-
ing field of dissemination and implementation 
science (D&I) can help to speed the spread and 
adoption of new ideas into clinical practice, and 
(3) to identify next steps toward incorporat-
ing D&I science into plastic and reconstructive 
surgery.
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Summary: Plastic and reconstructive surgery has an illustrious history of 
innovation. The advancement, if not the survival, of the specialty depends 
on the continual development and improvement of procedures, practices, 
and technologies. It follows that the safe adoption of innovation into clini-
cal practice is also paramount. Traditionally, adoption has relied on the dif-
fusion of new knowledge, which is a consistent but slow and passive process. 
The emerging field of dissemination and implementation science promises 
to expedite the spread and adoption of evidence-based interventions into 
clinical practice. The field is increasingly recognized as an important func-
tion of academia and is a growing priority for major health-related fund-
ing institutions. The authors discuss the contemporary challenges of the 
safe implementation and dissemination of new innovations in plastic and 
reconstructive surgery, and call on their colleagues to engage in this grow-
ing field of dissemination and implementation science. (Plast. Reconstr. 
Surg. 147: 304e, 2021.)
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EXISTING STRATEGIES TO PROMOTE 
INNOVATION IN PLASTIC AND 
RECONSTRUCTIVE SURGERY
Despite the ubiquity of the term, there is no 
consensus over what constitutes surgical innova-
tion. Here, we define surgical innovation as (1) 
the introduction of an entirely new procedure or 
technology/product used for a procedure, (2) 
the development of a substantial modification to 
an existing procedure or technology/product for 
a procedure, or (3) the application of an existing 
procedure/technology/product to a new anatom-
ical site or a new patient population.11,13
Implicit in this definition is some uncertainty 
regarding the procedure’s risks and/or benefits 
over other available treatments, and innovation 
does not necessarily imply improvement. Indeed, 
ethical innovation in any surgical discipline 
demands robust evaluation of safety, efficacy, and 
effectiveness.14,15 The decision to offer an innovative 
procedure should depend on the patient’s goals 
and expectations, the surgeon’s experiences and 
incentives, the operative risks and available alterna-
tives, and impact on society. In effect, this decision 
should be difficult, and may often require exper-
tise beyond an individual surgeon’s training. These 
considerations are often particularly complex in 
plastic and reconstructive surgery, as both aesthetic 
and reconstructive surgeons routinely work with 
vulnerable patient populations. Adequate over-
sight of safe innovation in plastic and reconstruc-
tive surgery remains an unmet need.
In recent years, multiple studies and societal 
groups have proposed strategies to promote the 
ethical development and application of surgical 
innovations.10,14,16–20 In general, these strategies can 
be categorized as either surgeon-level or systems-
level processes. Surgeon-level processes involve 
strategies to facilitate shared decision-making and 
informed consent, provide additional technical 
training, and improve education on surgical ethics. 
Proposed systems-level processes include oversight 
by ethics and/or specialized innovation commit-
tees, approval by institutional review boards, lon-
gitudinal evaluation by accreditation or regulatory 
groups, changes in incentive structures, and adher-
ence to reporting guidelines in peer-reviewed pub-
lications. The IDEAL framework, for example, 
provides a five-stage pathway from preclinical stud-
ies to patient registries through which surgical pro-
cedures should be developed and assessed.16,17
Unfortunately, implementing these strategies 
has proven difficult. A recent international survey 
of plastic surgeons found that half did not con-
sider institutional review board approval to be 
of high importance for surgical innovation, and 
respondents reported low familiarity with ethics 
of surgical innovation.13 Despite repeated calls in 
their support, oversight committees and regula-
tory bodies have not been widely implemented.10 
Concerns have also been raised that such groups 
may stifle innovation, which could jeopardize 
rather than promote patient safety.18
In this context, it is unlikely that any strategy 
will be effective or sustainable in isolation. For 
realistic reform, an understanding of how innova-
tions are spread and adopted, and how these pro-
cesses may be improved, is needed.
Understanding How Innovations Are Spread
Thomas Kuhn described scientific develop-
ment as “a succession of tradition-bound periods 
that are punctuated by sudden breaks and para-
digm shifts.”21 However, a necessary stage between 
the development of an innovation and its eventual 
adoption is the process by which the innovation is 
spread. Everett Rogers proposed the diffusion of 
innovation paradigm in 1962 as a universal, gen-
eral process of social change (Fig. 1).22 Diffusion, 
in this context, is the passive spread of an idea or 
innovation over time to members of a social system 
through existing channels. Diffusion of innova-
tion seeks to describe why it routinely takes several 
years for an innovation to gain widespread adop-
tion, and why an innovation that is superior to 
existing methods may actually never be adopted.
Rogers defined five types of adopters in his 
paradigm, each with distinct roles in the diffusion 
process and relations to the “circle of local peer 
networks” (Fig. 1). Innovators are outside the peer 
network, which frees them from constraints of a 
local system and allows them to generate new ideas. 
Early adopters, well respected within the local sys-
tem, are the first to accept an innovation. They have 
the resources and risk tolerance to try new ideas. 
In health care, the early adopters are commonly 
elected leaders or representatives of clinical groups. 
Their status decreases the uncertainty of a new idea, 
which allows it to spread to the early majority, who 
tend to embrace innovation but seldom hold posi-
tions of leadership. If there are no early adopters to 
communicate a new idea, endorse it, and decrease 
its uncertainty, the innovation will be rejected and 
fail to achieve widespread adoption.
It is also important that early adopters mod-
ify the innovation (often, this means simplifying 
the innovation) to promote and teach the new 
idea.22 Once adoption has reached a critical level 
of 15 to 20 percent of members in the local sys-
tem, the idea spreads rapidly to most of the rest of 
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the system (i.e., “tipping point”), including to the 
late majority and the laggards, who are suspicious 
and/or resistant to change.22 This spontaneous, 
passive process takes time. Indeed, the treat-
ment and prevention of scurvy with vitamin C, for 
example, took over two centuries to be accepted, 
and the more efficient Dvorak keyboard never 
replaced the less efficient QWERTY keyboard that 
is still used today.12,22 Another analogy is the time 
it takes in the rise (Roger’s diffusion of innova-
tion) and then fall of a surgical technique, known 
together as Scott’s parabola (Fig. 2).23
WHAT CONTROLS THE SPEED OF 
DIFFUSION?
The speed of diffusion is governed by (1) char-
acteristics of the adopters, (2) characteristics of 
the innovation itself, and (3) contextual factors.24 
Surgeon adopters may be wary of a new interven-
tion if what he or she has been doing “works well 
in his/her hands.” Studies on the neuroscience of 
learning suggest that, as a species, we are hardwired 
to resist change and innovation, and instead seek 
safety in constancy and predictability.25 Moreover, 
our emotions affect learning. In his book Descartes’ 
Error,26 Antonio Damasio describes how emotions 
“create an enduring or nontransient memory, 
unique in its intensity”27 that does not require the 
usual repetition to ensure a memory is sustained. 
A single patient, or a single surgical encoun-
ter, can be so powerful that it imprints an indel-
ible learning moment. Innovation-specific factors 
include its complexity (simple ideas spread more 
quickly), trialability (or the ability to test it on a 
small scale), and observability (whether its effects 
Fig. 1. Diffusion of innovation. The bell-shaped curve (black) describes the diffusion of inno-
vation across the social groups of innovators, early adopters, early majority, late majority, 
and laggards. The S-curve (blue) describes the percentage of adoption across these social 
groups. The tipping point occurs when an idea reaches 15 to 20 percent of adoption in 
the local system, essentially transitioning into the early majority, after which there is rapid 
“unstoppable” adoption in the group. (Modified from Rogers EM. Diffusion of Innovations. 
5th ed. New York: Simon & Schuster; 2003. Adaptations are themselves works protected 
by copyright. So in order to publish this adaptation, authorization must be obtained both 
from the owner of the copyright in the original work and from the owner of copyright in 
the translation or adaptation.)
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are easily apparent). Important contextual fac-
tors include an organization’s culture, leadership, 
communication and incentive structure, history, 
and current needs. For example, health care orga-
nizations that foster social exchanges between 
innovators and early adopters, and between early 
adopters and the early majority, will see faster dif-
fusion than organizations that discourage it or are 
simply indifferent.
The factors may explain differences in the 
uptake of practices in plastic and reconstructive 
surgery. For example, nerve transfer, now a stan-
dard technique for the management of peripheral 
nerve injuries, has had poor adoption in the tetra-
plegic population despite its first successful appli-
cation over 10 years ago.28 In contrast, the use of 
allograft for the treatment of bony hand and wrist 
defects had very rapid uptake, despite good evi-
dence suggesting its inferiority to autograft.29
THE BEGINNINGS OF D&I SCIENCE
With the accelerated pace of scientific advance-
ments, the gap between evidence-based medicine, 
or the care that could be provided, and actual 
clinical practice continues to widen.30 Indeed, it is 
estimated that it takes 17 years for just 14 percent 
of medical research to influence patient care.12 
In the years since the introduction of the diffu-
sion of innovations paradigm, focus has shifted 
toward means of improving and operationalizing 
the spread and adoption of ideas.31 Collectively, 
these investigations constitute a new area of study, 
D&I science.
The field of D&I science has been described 
in multiple terms, including “research transla-
tion,”32 “knowledge translation,”33 “knowledge to 
action,”34 “evidence-based policy and practice,”35 
and “research implementation,” among others. 
Although this inconsistency of terminology may 
create confusion,32,36 each term emphasizes the 
active, directed, and planned spread of knowl-
edge. D&I science promises to speed the safe 
translation of medical research knowledge into 
widespread clinical practice by moving Scott’s 
parabola to the left (Fig.  3), and to narrow the 
quality gap in health care.37 The two interrelated 
components of D&I research are dissemination 
science, the study of how knowledge and inter-
ventions can best be actively communicated to 
potential adopters, and implementation science, 
the study of how an intervention is actually put 
into practice.37
The field of D&I science has grown exponen-
tially over the past decade. It is increasingly rec-
ognized as an important function of academia, 
and is a growing priority for major health-related 
funders, including the National Institutes of 
Health.38 Several peer-reviewed journals have 
devoted special issues or sections to the topic of 
implementation of evidence-based practices.39–48 
For example, the impact factor for the open-
access peer-reviewed journal Implementation Science, 
dedicated entirely to D&I science research, rose 
Fig. 2. Scott’s parabola. If the S-curve of adoption is extended to represent when an idea falls into disuse, the curve becomes what 
is known in surgery as Scott’s parabola—the rise and fall of a surgical technique. Roger’s diffusion of innovation is considered the 
first half of Scott’s parabola. (Modified from Scott JW. Scott’s parabola: The rise and fall of a surgical technique. BMJ 2001;323:1447. 
Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained 
both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.)
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quickly from 2.93 after its first year of publication 
in 2006 to 5.65 by 2014. The uptake of D&I sci-
ence in surgery, however, has been comparatively 
slow. In fact, it could be said that early adopters of 
D&I research, specifically in the surgical special-
ties, have yet to be identified.
A D&I APPROACH TO INNOVATION 
IN PLASTIC AND RECONSTRUCTIVE 
SURGERY
A D&I science approach involves (1) an evi-
dence-based intervention (the issue of what con-
stitutes evidence-based practices in plastic and 
reconstructive surgery is addressed below; see 
Contemporary Challenges in D&I Science) to be 
scaled-up or introduced to a new patient popula-
tion; (2) planned strategies to promote the dis-
semination, implementation, and sustainability 
of the intervention; and (3) validated approaches 
to evaluate whether the strategies were effective.49 
Rather than relying on intuition or trial-and-error, 
D&I uses validated models, often referred to as 
frameworks or theories, to achieve these aims.
Popular models used in D&I research include 
the Consolidated Framework for Implementation 
Research, knowledge-to-action, promoting action 
on research implementation in health services, 
RE-AIM, and translation research continuum or 
Fig. 3. Implementation and deimplementation. The field of dissemination and implementation (blue) promises to speed the 
adoption of innovation, essentially reducing the time for surgeons to adopt a new technique. This aims to truncate the time-
line of Roger’s parabola for diffusion of innovation and the first half of Scott’s parabola with the rise of a surgical technique. 
Deimplementation (green), a new subfield within dissemination and implementation science, studies the process of when innova-
tion falls into disuse, promising its quick and safe exit, and thereby making room for the next innovation. This aims to truncate the 
timeline of the second half of Scott’s parabola with the fall of a surgical technique. OR, operating room.
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T models.32 Choice of model depends on the pur-
pose of the D&I study and on investigator pref-
erence. For example, RE-AIM was created as a 
five-step framework (reach, efficacy, adoption, 
implementation, and maintenance) to conceptual-
ize the public health impact of an intervention.50 
Whereas RE-AIM outlines criteria for the successful 
implementation of an intervention, the T models 
depict a general pathway in medical research from 
ideation to implementation.51 The steps in this 
pathway include T0 (description and discovery),52 
T1 (basic science to clinical research), T2 (clinical 
research to clinical practice),38 T3 (clinical practice 
to large-scale dissemination),49 and T4 (large-scale 
dissemination to population health outcomes).53
Irrespective of the selected model, the foun-
dation of any D&I project is an understanding of 
context. An understanding of context can help to 
explain why surgical innovations are taken up in 
some areas but not in others, such as geographic 
variation in endoscopic versus open carpal tun-
nel release,54 or the use of custom computer-
assisted design and manufactured implants in 
North America but less so in resource-restricted 
countries. The Consolidated Framework for 
Implementation Research model recommends 
examining the inner setting, outer setting, and 
characteristics of individuals for contextual 
assessment.51 The inner setting may involve an 
understanding of a hospital’s resources; an orga-
nization’s culture to accept or prioritize change; 
or the relationships between physicians, patients, 
and hospital administrators. The outer setting may 
refer to how a plastic and reconstructive surgery 
department interacts with the greater surgical, 
regulatory, or patient community. Assessing the 
outer setting may, for example, involve describing 
what external financial incentives or disincentives 
influence surgeons’ behaviors. Lastly, characteris-
tics of individuals may refer to how surgeons view 
their own responsibility to follow ethical prac-
tices and what they consider to be ethical prac-
tice. These constructs may be evaluated through 
interviews, surveys, or consensus conferences, 
but they remain poorly described in plastic and 
reconstructive surgery. An understanding of con-
text can help to explain why surgical innovations 
are taken up in some geographic areas but not in 
others.
The next step in a D&I study is to formulate 
strategies to address barriers identified during 
contextual assessment. Several validated strategies 
have been developed to overcome common imple-
mentation barriers.49 As described by Proctor et 
al.,49 a D&I project should use multiple strategies 
to facilitate change at multiple levels, including 
the systems and individual levels. Many previously 
suggested methods for promoting ethical inno-
vation, such as ethics training for surgeons or 
oversight committees, are potential implementa-
tion strategies. Choice of strategy depends on the 
purpose of the study and on the contextual assess-
ment. After all, an oversight committee instituted 
at a hospital with little funding or surgeon interest 
would be unlikely to achieve its intended purpose.
The last component of a D&I study is to assess 
whether its implementation strategies are success-
ful. Commonly evaluated outcomes are acceptabil-
ity, adoption, feasibility, fidelity, and sustainability 
(Table 1).49,55,56 An important distinction between 
traditional D&I research and clinical research is 
that success is defined by how well the intervention 
is disseminated or implemented rather than by 
improvements in clinical outcomes57,58 (or “effec-
tiveness research”59). The traditional assump-
tion for D&I research is that the evidence-based 
intervention will work as published, provided 
that it is appropriately implemented. However, 
this assumption is not always realistic, particularly 
when the evidence for an intervention is relatively 
modest or when the intervention’s generalizabil-
ity has not yet been established. Hybrid designs 
have been developed that combine D&I and effec-
tiveness research; they are defined by how much 
emphasis is placed on testing the implementation 
strategies versus gathering clinical information on 
the intervention.58
DEIMPLEMENTATION OF HARMFUL OR 
INEFFECTIVE INTERVENTIONS
In addition to promoting the uptake of evi-
dence-based interventions, there is also a need 
to replace or abandon existing interventions 
that are harmful or ineffective. This process of 
deimplementation (the right half of Scott’s parab-
ola) (Fig.  3) has intuitive implications for surgi-
cal innovation, and it is a fledgling area of study 
within D&I science.60 Speeding the discontinua-
tion of less effective alternatives makes room for 
new innovations and interventions, and deim-
plementation may also help curtail the inappro-
priate spread of new yet harmful practices. The 
development of distal nerve transfers for proxi-
mal nerve injuries highlights the importance of 
deimplementation in the innovation process. 
Traditionally, these injuries have been managed 
with nerve grafting. However, the introduction of 
nerve transfer surgery takes advantage of nearby 
expendable nerves to convert a more proximal 
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injury to a distal injury, thereby shortening rein-
nervation time and leading to superior func-
tional outcomes.61,62 Unfortunately, even nerve 
repair with tension and joint flexion are still used 
to repair nerve gaps by some surgeons. Other 
examples in plastic and reconstructive surgery 
include the deimplementation of Allergan Biocell 
(Allergan Medical Corporation, Santa Barbara, 
Calif.) textured breast implants63,64 and titanium 
mesh cranioplasties.65,66 D&I models to guide 
deimplementation efforts are active areas of study.
Of course, not all innovations undergo deim-
plementation. Some innovations ride the crest of 
adoption for a very long time before an improve-
ment or new innovation replaces the existing 
innovation (Fig. 4). The goal of D&I science is to 
retain adoption until a new innovation becomes 
the standard of care.
CONTEMPORARY CHALLENGES IN  
D&I SCIENCE
Although the goal of D&I science is to promote 
implementation of an evidence-based intervention, 
the amount and level of evidence required before 
an innovation is considered ready for dissemina-
tion in surgery remains an unanswered question.67 
Indeed, the majority of published studies in plastic 
and reconstructive surgery journals offer relatively 
low-quality evidence.68–70 As such, hybrid designs,58 
which gather clinical information while also testing 
implementation strategies, rather than traditional 
D&I studies may be most applicable in plastic and 
reconstructive surgery (Fig. 5).
Furthermore, because of restrictive inclusion 
criteria, high-level evidence from randomized tri-
als is often not directly applicable to the major-
ity of patients seen in everyday clinical practice. 
Recently, practice-based research networks have 
been developed to better understand issues aris-
ing in daily practice and the gap between recom-
mended and actual care.71 Academic institutions 
may play an important role in collaborating with 
community clinicians through practice-based 
research networks to encourage the uptake of new 
interventions and practices; this includes those in 
private and hybrid practices.
Finally, the use of new media and emerging 
technologies also accelerates the rate at which 
information is disseminated.72 They allow for the 
creation of large, online communities37 and have 
been shown to expand reach in health promo-
tion,73 disease prevention,74 telehealth,75,76 and 
cybermedicine.77 However, these modalities may 
also lead to the spreading of misinformation, as 
exemplified by the rise in the modern antivaccine 
campaign.78 The safe and ethical use of media and 
technology to disseminate new information is a 
necessary but unmet need.
A CALL TO ACTION
Ensuring the widespread adoption of neces-
sary practices in plastic and reconstructive surgery 
requires a realignment of academic and finan-
cial incentives. Although considerable emphasis, 
time, and funding is placed on developing innova-
tions, there is comparatively little focus on sharing 
Table 1. Common Implementation Outcomes and Definitions Proposed by Proctor et al.*
Outcome Definition Example Measure
Acceptability How agreeable an innovation or set of implementation strate-
gies is to stakeholders
EBPAS†
Adoption The uptake of an innovation among stakeholders Survey assessing the fraction of surgeons 
who have offered the innovative procedure 
when indicated
Feasibility The degree to which an innovation can be used in actual 
practice; it is distinct from acceptability, in that an innova-
tion may be agreeable but impractical for a setting because 
of resource or training limitations
Semistructured interviews with surgeons 
and/or hospital administrators
Fidelity Adherence to the implementation protocol; it describes the 
match between how an innovation was meant to be imple-
mented and how it was actually implemented
SDM-Q-9 questionnaire‡
Sustainability The degree to which an innovation or a set of implementa-
tion strategies is maintained over time; it reflects the stable 
integration of the practice within an organization
A follow-up survey assessing long-term fidel-
ity and adoption
EBPAS, Evidence-Based Practice Attitude Scale; SDM-Q-9, nine-item Shared Decision-Making Questionnaire.
*Proctor E, Silmere H, Raghavan R, et al. Outcomes for implementation research: Conceptual distinctions, measurement challenges, and 
research agenda. Adm Policy Ment Health 2011;38:65–76.
†Aarons GA. Mental health provider attitudes toward adoption of evidence-based practice: The Evidence-Based Practice Attitude Scale 
(EBPAS). Ment Health Serv Res. 2004;6:61–74.
‡Kriston L, Scholl I, Hölzel L, Simon D, Loh A, Härter M. The 9-item Shared Decision Making Questionnaire (SDM-Q-9): Development and 
psychometric properties in a primary care sample. Patient Educ Couns. 2010;80:94–99.
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innovations once developed. In the present system, 
an innovating surgeon may be rewarded for devel-
oping and hoarding a new intervention, becom-
ing the expert on that procedure and collecting 
referrals. However, establishing a culture and 
system to facilitate the sharing of ideas is essential 
for advancement of plastic and reconstructive sur-
gery, and demands new perspectives in health care 
policy, health care delivery, and reimbursement.79 
The current business model of reimbursing for 
Fig. 4. Sustainability of an innovation. Adoption of a new innovation (innovation #2) necessarily leads to deimplementation of an 
existing innovation (innovation #1). The goal of dissemination and implementation science is to retain adoption until a new inno-
vation becomes the standard of care, termed “sustainability.”
Fig. 5. Translating an innovation from idea to society. The fields of basic science, translational science, clinical research, knowledge 
translation, implementation science, and policy change all play an important role in bringing an innovation from idea to society. 
Plotted over time, these fields overlap and occur concurrently. Hybrid designs (Glasgow RE, Vogt TM, Boles SM. Evaluating the 
public health impact of health promotion interventions: The RE-AIM framework. Am J Public Health 1999;89:1322–1327), which 
gather clinical information (levels V through I evidence) while also testing implementation strategies, rather than traditional dis-
semination and implementation science studies, may be most applicable in plastic and reconstructive surgery. (Modified from 
2018 Translational Research Program, University of Toronto. Adaptations are themselves works protected by copyright. So in order 
to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the 
owner of copyright in the translation or adaptation.)
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high–relative value unit procedures in many aca-
demic departments stifles both scholarship and 
innovation, and D&I science emphasizes collabo-
ration over competition. This cultural shift will 
require input from all stakeholders, including 
the plastic surgery community-at-large, govern-
ing organizations, policy makers, even patients 
themselves. The role that each of these stakehold-
ers will play remains to be determined. A poten-
tial starting point could be increased funding 
by plastic and reconstructive surgery organiza-
tions (e.g., Plastic Surgery Foundation, American 
Association of Plastic Surgeons) for CME activi-
ties and research in D&I science. This could be 
a single strategy in a multifaceted plan to bring 
about larger, systemic change. Although these 
issues are shared across surgical disciplines, plas-
tic surgeons are perhaps uniquely situated to lead 
such reforms, given the fundamental importance 
of innovation to the specialty.
The emerging field of D&I science provides 
strategies to study and facilitate the safe spread 
and adoption of surgical innovations. It is imper-
ative that, as a group, we become involved in 
this growing field, and address the contempo-
rary issues facing our specialty. These next steps 
include the following:
• Defining evidence in plastic and recon-
structive surgery: what level of evidence is 
required to disseminate a new innovation?
• Advocating for culture change and financial 
support to foster the spread of innovations.
• Applying D&I models to new innovations to 
ensure their adoption.
• Actively deimplementing harmful or inef-
fective interventions.
• Using media responsibly to spread innovation.
• Developing and participating in practice-
based research networks.
• Developing and maintaining an awareness 
of our own personal resistance to change.
• Engaging with meetings and journals that 
focus on D&I science.
Through such efforts, we will continue to 
accelerate improvements in the safety and qual-
ity of surgical care in plastic and reconstructive 
surgery.
Susan E. Mackinnon, M.D.
Division of Plastic and Reconstructive Surgery
Washington University in St. Louis
660 South Euclid Avenue, Campus Box 8238
St. Louis, Mo. 63110
mackinnons@wustl.edu
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